Satya Prakash Yadav/X
Aug 15, 2026, 16:00
Satya Prakash Yadav: Overcoming Overtreatment in Pediatric Immune Thrombocytopenia
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared Blood Journals Portfolio’s post on X, adding։
“Immune thrombocytopenia (ITP) in children is most over treated disorder.
No treatment still remains best treatment for most patients!
Don’t be scared of low platelets – These platelets are fresh platelets, large in size and functionally more powerful then older platelets.”
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions
-
Oct 2, 2026, 05:38Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
-
Oct 2, 2026, 05:29Mohammed Alo: Your LDL Isn’t a Snapshot – It’s a Smoking Habit Measured in Years
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT